TSPO2 translocates 5-aminolevulinic acid into human erythroleukemia cells.
Hana ManceauSophie D LefevreArienne MirmiranClaude HattabHugo R SugierCaroline SchmittKatell Peoc'hHerve PuyMariano Anibal OstuniLaurent GouyaJean-Jacques LacaperePublished in: Biology of the cell (2020)
This is the first characterisation of molecular mechanisms involving a new actor in ALA transport in ALA-induced PPIX accumulation in erythroleukemia cells, which could be inhibited by specific drug ligands.